Meyka Pro banner
BlackRock Capital Allocation Trust

BlackRock Capital Allocation Trust (BCAT) Stock Overview

Explore BlackRock Capital Allocation Trust’s financial performance, market position, analyst ratings, and future outlook.

BCATNYSE
Financial ServicesAsset Management
$15.90
$0.16(1.02%)
U.S. Market opens in 13h 38m

BlackRock Capital Allocation Trust (BCAT)

Meyka AI Score

Z

Key Financials

Market Cap1.7B
P/E Ratio7.66
EPS (TTM)$2.12
ROE0.13%
Fundamental Analysis

AI Price Forecasts

1 Month$16.36
3 Months$15.66
1 Year Target$15.41

BCAT Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of BlackRock Capital Allocation Trust (NYSE: BCAT) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, BlackRock Capital Allocation Trust's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of BCAT on the NYSE shows an RSI of 52.85, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $15.41 for the NYSE listing.

Key metrics behind BlackRock Capital Allocation Trust's NYSE-traded stock include a P/E ratio of 7.66 and a market capitalization of 1.7B. Combined with our AI analysis, these give both institutional and retail investors a clear view of BCAT on the NYSE.

Price Performance (NYSE: BCAT)

1-Day Change
1.07%
5-Day Change
-0.57%
1-Month Change
1.85%
3-Month Change
2.70%
6-Month Change
6.91%
Year-to-Date (YTD) Change
12.35%
1-Year Change
9.26%
3-Year Change
6.77%
5-Year Change
-26.01%
All-Time (Max) Change
-20.46%

Contact Information

Company Facts

IPO DateSep 25, 2020
CountryUS
Actively Trading

Frequently Asked Questions